These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 20128686)
1. Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications. Gabril M; White NM; Moussa M; Chow TF; Metias SM; Fatoohi E; Yousef GM Biol Chem; 2010 Apr; 391(4):403-9. PubMed ID: 20128686 [TBL] [Abstract][Full Text] [Related]
2. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642 [TBL] [Abstract][Full Text] [Related]
3. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994 [TBL] [Abstract][Full Text] [Related]
4. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney. Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364 [TBL] [Abstract][Full Text] [Related]
6. Significance of Fas expression alteration during tumor progression of renal cell carcinoma. Sejima T; Miyagawa I Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620 [TBL] [Abstract][Full Text] [Related]
7. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570 [TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Rodins K; Cheale M; Coleman N; Fox SB Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes. Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095 [TBL] [Abstract][Full Text] [Related]
10. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598 [TBL] [Abstract][Full Text] [Related]
11. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue. Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872 [TBL] [Abstract][Full Text] [Related]
12. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188 [TBL] [Abstract][Full Text] [Related]
13. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma. Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582 [TBL] [Abstract][Full Text] [Related]
14. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of activator protein-2 isoforms in renal cell carcinoma. Oya M; Mikami S; Mizuno R; Miyajima A; Horiguchi Y; Nakashima J; Marumo K; Mukai M; Murai M Urology; 2004 Jul; 64(1):162-7. PubMed ID: 15245963 [TBL] [Abstract][Full Text] [Related]
16. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips]. Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215 [TBL] [Abstract][Full Text] [Related]
17. Expression of S-100 protein in renal cell neoplasms. Lin F; Yang W; Betten M; Teh BT; Yang XJ; Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922 [TBL] [Abstract][Full Text] [Related]
18. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Yusenko MV; Kovacs G Histopathology; 2009 Dec; 55(6):687-95. PubMed ID: 20002769 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731 [TBL] [Abstract][Full Text] [Related]
20. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma. Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]